The company aims to expand its position within advanced wound care by introducing a new silicone foam that will benefit both healthcare professionals and.
Friday, 9 February 2024 at 11.00 - 12.00 CETIn connection with the publication of Coloplast’s interim financial results for Q1 2023/24, to be released same.
Coloplast A/S (OTCMKTS:CLPBF – Get Free Report) saw a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 736,700 shares, an increase of 36.3% from the November 30th total of 540,400 shares. Based on an average trading volume of 200 shares, the days-to-cover ratio is […]
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) and Precision Optics (NASDAQ:POCI – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, dividends, earnings and valuation. Insider & Institutional Ownership 0.1% of Coloplast A/S […]
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) saw a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 800 shares, a decline of 79.5% from the November 15th total of 3,900 shares. Based on an average trading volume of 93,600 shares, the short-interest ratio is […]